Cash flow Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 13/02/2026			5-day change	1st Jan Change
13.60 ^CNY	-0.95%		-5.88%	-4.23%

12-24	Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits	MT
12-16	Shenzhen YHLO Biotech Gets Chinese Provincial Regulator's Approval for Two Autoimmune Disease Testing Kits	MT

bfa021f63decd.bOry0H8b0o97q9zS5xab_QHkyRxbUBLpSwBpPvxjZbo.Ip-zlCsssd0Dxoa80nLRyDC3hmw0EnuABnA8B4w2UNBahZvhDSqc_k3Zsw

Published financial data: SHENZHEN YHLO BIOTECH CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	963M	1.13B	3.93B	2.02B	1.97B
Other Revenues, Total	35.99M	44.37M	51.13M	34.69M	37.93M
Total Revenues	999M	1.18B	3.98B	2.05B	2.01B
Cost of Goods Sold, Total	410M	524M	1.94B	949M	720M
Gross Profit	589M	654M	2.04B	1.1B	1.29B
Selling General & Admin Expenses, Total	242M	303M	618M	565M	607M
Provision for Bad Debts	1.95M	2.88M	11.52M	7.5M	10.58M
R&D Expenses	102M	129M	238M	314M	331M
Other Operating Expenses	8.17M	8.09M	30.2M	1.57M	7.2M
Other Operating Expenses, Total	354M	443M	898M	888M	956M
Operating Income	235M	211M	1.15B	216M	335M
Interest Expense, Total	-13.17M	-11.22M	-8.41M	-6.25M	-12.18M
Interest And Investment Income	1.95M	8.33M	14.4M	132M	4.86M
Net Interest Expenses	-11.23M	-2.89M	5.99M	126M	-7.33M
Currency Exchange Gains (Loss)	-5.1M	-2.76M	9.71M	3.06M	-735K
Other Non Operating Income (Expenses)	-305K	-858K	-23.65M	-1.59M	-3.2M
EBT, Excl. Unusual Items	219M	204M	1.14B	343M	324M
Gain (Loss) On Sale Of Investments	-	146K	54.45M	-32.73M	-31.52M
Gain (Loss) On Sale Of Assets	-15.22K	-	-3.39M	2.07M	1.82M
Asset Writedown	-1.26M	-200K	-10.33M	-9.08M	-10.84M
Other Unusual Items	24.26M	23.75M	7.8M	30.67M	28.05M
EBT, Incl. Unusual Items	242M	228M	1.19B	334M	312M
Income Tax Expense	33.54M	23.91M	165M	54.91M	39.5M
Earnings From Continuing Operations	208M	204M	1.02B	279M	272M
Net Income to Company	208M	204M	1.02B	279M	272M
Minority Interest	2.57M	901K	-9.13M	75.81M	29.34M
Net Income - (IS)	211M	205M	1.01B	355M	302M
Net Income to Common Incl Extra Items	211M	205M	1.01B	355M	302M
Net Income to Common Excl. Extra Items	211M	205M	1.01B	355M	302M
Per Share Items
Net EPS - Basic	0.41	0.38	1.79	0.63	0.53
Basic EPS - Continuing Operations	0.41	0.38	1.79	0.63	0.53
Basic Weighted Average Shares Outstanding	508M	541M	566M	564M	569M
Net EPS - Diluted	0.41	0.38	1.78	0.62	0.53
Diluted EPS - Continuing Operations	0.41	0.38	1.78	0.62	0.53
Diluted Weighted Average Shares Outstanding	508M	541M	569M	573M	570M
Normalized Basic EPS	0.27	0.24	1.24	0.52	0.41
Normalized Diluted EPS	0.27	0.24	1.23	0.51	0.41
Dividend Per Share	-	0.29	0.45	0.27	0.21
Payout Ratio	17.21	5.32	16.69	79.58	56.06
Supplemental Items
EBITDA	304M	304M	1.28B	398M	575M
EBITA	238M	217M	1.16B	236M	358M
EBIT	235M	211M	1.15B	216M	335M
EBITDAR	308M	311M	1.29B	410M	591M
Total Revenues (As Reported)	-	-	3.98B	2.05B	2.01B
Effective Tax Rate - (Ratio)	13.89	10.5	13.9	16.43	12.67
Total Current Taxes	27.94M	27.16M	184M	59.29M	40.35M
Total Deferred Taxes	5.61M	-3.25M	-19.12M	-4.38M	-848K
Normalized Net Income	139M	128M	702M	290M	232M
Interest Capitalized	6.02M	849M	5.38M	17.26M	8.96M
Non-Cash Pension Expense	216K	265K	974K	1.03M	4.3M
Supplemental Operating Expense Items
Advertising Expense	12.1M	23.15M	188M	36.49M	31.66M
Marketing Expenses	2.56M	3.56M	905K	2.38M	6.19M
Selling and Marketing Expenses	178M	214M	483M	386M	425M
General and Administrative Expenses	60.41M	85.21M	131M	172M	172M
Research And Development Expense From Footnotes	103M	131M	240M	317M	337M
Net Rental Expense, Total	4.61M	7.19M	8.24M	12.06M	15.64M
Imputed Operating Lease Interest Expense	2.36M	180M	2.57M	4.4M	3.61M
Imputed Operating Lease Depreciation	2.24M	-173M	5.67M	7.66M	12.02M
Maintenance & Repair Expenses, Total	-	-	8.12M	5.4M	5.3M
Stock-Based Comp., R&D Exp. (Total)	-	-	9.18M	5.05M	7.35M
Stock-Based Comp., S&M Exp. (Total)	-	-	5.62M	4.67M	3.68M
Stock-Based Comp., G&A Exp. (Total)	-	-	6.6M	3.68M	5.06M
Total Stock-Based Compensation	-	-	21.41M	13.4M	16.09M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	232M	479M	1.25B	491M	465M
Short Term Investments	-	-	68.57M	144M	182M
Trading Asset Securities, Total	-	16.15M	114M	76.66M	69.59M
Total Cash And Short Term Investments	232M	495M	1.43B	711M	717M
Accounts Receivable, Total	214M	254M	346M	414M	524M
Other Receivables	5.3M	10.41M	66.2M	48.11M	54.23M
Total Receivables	219M	265M	413M	462M	578M
Inventory	298M	364M	570M	635M	671M
Other Current Assets, Total	44.45M	54.4M	79.72M	43.08M	45.98M
Total Current Assets	794M	1.18B	2.5B	1.85B	2.01B
Gross Property Plant And Equipment	580M	916M	1.42B	1.89B	2.44B
Accumulated Depreciation	-155M	-244M	-372M	-514M	-704M
Net Property Plant And Equipment	425M	672M	1.04B	1.37B	1.74B
Long-term Investments	-	75.42M	303M	261M	358M
Goodwill	-	-	5.29M	5.29M	5.29M
Other Intangibles, Total	35.75M	104M	210M	189M	183M
Accounts Receivable Long-Term	3.99M	3.76M	-	-	-
Deferred Tax Assets Long-Term	13.53M	16.81M	48.42M	47.68M	44.01M
Deferred Charges Long-Term	25.05M	22.87M	36.15M	43.12M	26.97M
Other Long-Term Assets, Total	26.09M	65.05M	69.9M	37.89M	51M
Total Assets	1.32B	2.14B	4.21B	3.81B	4.42B
Liabilities
Accounts Payable, Total	73.74M	138M	308M	204M	213M
Accrued Expenses, Total	49.46M	54.88M	211M	146M	164M
Short-term Borrowings	302M	151M	279M	171M	292M
Current Portion of Long-Term Debt	-	-	-	-	23.8M
Current Portion of Leases	4.71M	4.73M	5.05M	1.07M	1.84M
Current Income Taxes Payable	15.16M	12.27M	75.73M	13.27M	4.59M
Unearned Revenue Current, Total	58.94M	111M	529M	184M	184M
Other Current Liabilities	16.54M	40.79M	126M	123M	173M
Total Current Liabilities	521M	512M	1.53B	841M	1.06B
Long-Term Debt	-	73.26M	184M	382M	585M
Long-Term Leases	8.09M	4.89M	5.24M	3.57M	2.39M
Unearned Revenue Non Current	30.8M	33.25M	29.75M	36.7M	62.52M
Deferred Tax Liability Non Current	-	21.97K	14.1M	9.06M	4.54M
Other Non Current Liabilities	-	-	-	-	740K
Total Liabilities	559M	624M	1.77B	1.27B	1.71B
Common Stock, Total	364M	405M	567M	568M	570M
Additional Paid In Capital	13.24M	525M	390M	432M	480M
Retained Earnings	391M	596M	1.45B	1.55B	1.69B
Comprehensive Income and Other	-499K	-120K	13.84M	13.53M	14.38M
Total Common Equity	768M	1.53B	2.42B	2.56B	2.76B
Minority Interest	-3.81M	-11.49M	28.13M	-26.27M	-55.32M
Total Equity	764M	1.51B	2.44B	2.53B	2.7B
Total Liabilities And Equity	1.32B	2.14B	4.21B	3.81B	4.42B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	510M	567M	567M	568M	570M
ECS Total Common Shares Outstanding	510M	567M	567M	568M	570M
Book Value / Share	1.51	2.69	4.26	4.51	4.83
Tangible Book Value	732M	1.42B	2.2B	2.37B	2.57B
Tangible Book Value Per Share	1.44	2.51	3.88	4.16	4.5
Total Debt	315M	234M	474M	558M	906M
Net Debt	82.45M	-261M	-960M	-153M	189M
Debt Equivalent Oper. Leases	36.87M	57.51M	65.94M	96.48M	125M
Minority Interest, Total (Incl. Fin. Div)	-3.81M	-11.49M	28.13M	-26.27M	-55.32M
Equity Method Investments, Total	-	35.05M	45.47M	140M	143M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	120M	122M	291M	253M	202M
Inventories - Work In Process, Total	12.45M	51.03M	48.08M	148M	129M
Inventories - Finished Goods, Total	175M	201M	310M	350M	362M
Buildings, Total	163M	222M	322M	343M	892M
Machinery, Total	385M	583M	818M	1.07B	1.37B
Full Time Employees	-	-	1.84K	1.76K	-
Assets under Capital Lease - Gross	31.98M	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-23.78M	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	11.9M	14.25M	24.53M	24.07M	38.55M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	211M	205M	1.01B	355M	302M
Depreciation & Amortization - CF	65.83M	90.98M	132M	175M	222M
Amortization of Goodwill and Intangible Assets - (CF)	2.6M	6.49M	10.94M	19.99M	22.92M
Depreciation & Amortization, Total	68.43M	97.47M	143M	195M	245M
Amortization of Deferred Charges, Total - (CF)	5.3M	7.06M	31.74M	15.63M	11.2M
(Gain) Loss From Sale Of Asset	15.22K	-	3.39M	-2.07M	-1.82M
(Gain) Loss on Sale of Investments - (CF)	-189K	2.82M	-59.84M	-85.35M	31.52M
Asset Writedown & Restructuring Costs	1.25M	200K	10.33M	9.08M	9.71M
Provision and Write-off of Bad Debts	14.31M	2.88M	11.07M	7.5M	10.58M
Other Operating Activities, Total	10.6M	26.25M	115M	-11.46M	-909K
Change In Accounts Receivable	-58.25M	-54.96M	-190M	12.93M	-131M
Change In Inventories	-20.87M	-67.37M	-341M	-102M	5.8M
Change In Accounts Payable	45.42M	43.78M	843M	-477M	33.01M
Change In Deferred Taxes	5.61M	-3.25M	-17.53M	-3.93M	-848K
Change in Other Net Operating Assets	-	-	21.41M	13.49M	15.64M
Cash from Operations	282M	260M	1.58B	-73.19M	530M
Capital Expenditure	-189M	-373M	-565M	-663M	-593M
Sale of Property, Plant, and Equipment	209K	-	30K	58.91K	22.9K
Cash Acquisitions	-	-	-6.3M	-	-26.44K
Divestitures	-	-	-	-21.57M	-
Investment in Marketable and Equity Securities, Total	-	-91.68M	-280M	22.25M	-161M
Other Investing Activities, Total	21.43M	3.27M	-17.71M	27.1M	5.5M
Cash from Investing	-168M	-461M	-870M	-635M	-749M
Long-Term Debt Issued, Total	660M	368M	683M	530M	572M
Total Debt Issued	660M	368M	683M	530M	572M
Long-Term Debt Repaid, Total	-630M	-454M	-450M	-288M	-233M
Total Debt Repaid	-630M	-454M	-450M	-288M	-233M
Issuance of Common Stock	-	562M	-	17.26M	21.11M
Common Dividends Paid	-36.23M	-10.9M	-169M	-283M	-169M
Common & Preferred Stock Dividends Paid	-36.23M	-10.9M	-169M	-283M	-169M
Other Financing Activities, Total	-2.81M	-17.15M	-51.03M	3.61M	-11.17M
Cash from Financing	-8.76M	448M	13.47M	-19.26M	181M
Foreign Exchange Rate Adjustments	-2.61M	-1.41M	10.25M	3.98M	-6M
Net Change in Cash	103M	245M	737M	-723M	-43.92M
Supplemental Items
Cash Income Tax Paid (Refund)	52.74M	80.03M	234M	146M	107M
Levered Free Cash Flow	-28.05M	-122M	856M	-966M	-203M
Unlevered Free Cash Flow	-19.82M	-115M	861M	-962M	-196M
Change In Net Working Capital	51.12M	-21.26M	-514M	658M	84.35M
Net Debt Issued / Repaid	30.28M	-86.17M	234M	242M	340M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	12.25	7.6	22.56	3.36	5.1
Return on Total Capital	15.14	9.31	30.7	4.48	6.26
Return On Equity %	30.98	17.9	51.61	11.22	10.4
Return on Common Equity	31.25	17.85	51.36	14.27	11.34
Margin Analysis
Gross Profit Margin %	58.93	55.49	51.34	53.77	64.2
SG&A Margin	24.22	25.7	15.52	27.54	30.2
EBITDA Margin %	30.39	25.81	32.25	19.37	28.58
EBITA Margin %	23.8	18.43	29.06	11.47	17.82
EBIT Margin %	23.54	17.88	28.79	10.5	16.68
Income From Continuing Operations Margin %	20.82	17.31	25.66	13.6	13.53
Net Income Margin %	21.07	17.38	25.43	17.29	14.99
Net Avail. For Common Margin %	21.07	17.38	25.43	17.29	14.99
Normalized Net Income Margin	13.93	10.9	17.64	14.14	11.53
Levered Free Cash Flow Margin	-2.81	-10.38	21.49	-47.06	-10.11
Unlevered Free Cash Flow Margin	-1.98	-9.79	21.63	-46.87	-9.73
Asset Turnover
Asset Turnover	0.83	0.68	1.25	0.51	0.49
Fixed Assets Turnover	2.56	2.15	4.64	1.7	1.3
Receivables Turnover (Average Receivables)	4.85	4.84	13.08	5.31	4.21
Inventory Turnover (Average Inventory)	1.45	1.58	4.15	1.58	1.1
Short Term Liquidity
Current Ratio	1.53	2.3	1.63	2.2	1.9
Quick Ratio	0.87	1.48	1.2	1.39	1.22
Operating Cash Flow to Current Liabilities	0.54	0.51	1.03	-0.09	0.5
Days Sales Outstanding (Average Receivables)	75.51	75.35	27.9	68.77	86.97
Days Outstanding Inventory (Average Inventory)	252.65	230.44	87.94	231.53	331.72
Average Days Payable Outstanding	53.44	65.38	37.93	92.07	100.88
Cash Conversion Cycle (Average Days)	274.72	240.41	77.91	208.23	317.82
Long Term Solvency
Total Debt/Equity	41.21	15.43	19.37	22.01	33.53
Total Debt / Total Capital	29.18	13.37	16.23	18.04	25.11
LT Debt/Equity	1.06	5.16	7.74	15.21	21.76
Long-Term Debt / Total Capital	0.75	4.47	6.48	12.47	16.29
Total Liabilities / Total Assets	42.27	29.17	41.95	33.43	38.81
EBIT / Interest Expense	17.85	18.77	136.31	34.47	27.53
EBITDA / Interest Expense	23.05	27.45	153.31	65.64	47.64
(EBITDA - Capex) / Interest Expense	8.67	-5.76	86.06	-40.33	-1.05
Total Debt / EBITDA	1.04	0.76	0.37	1.36	1.56
Net Debt / EBITDA	0.27	-0.85	-0.74	-0.37	0.33
Total Debt / (EBITDA - Capex)	2.76	-3.62	0.65	-2.21	-70.63
Net Debt / (EBITDA - Capex)	0.72	4.04	-1.33	0.61	-14.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.87	17.91	237.95	-48.42	-2.02
Gross Profit, 1 Yr. Growth %	34.9	15.67	215.53	-45.98	16.98
EBITDA, 1 Yr. Growth %	69.25	-8.61	313.88	-69.18	30.4
EBITA, 1 Yr. Growth %	80	-18.67	427.78	-79.67	30.95
EBIT, 1 Yr. Growth %	81.51	-20	443.48	-81.19	33.32
Earnings From Cont. Operations, 1 Yr. Growth %	96.04	-1.98	401.12	-72.66	-2.51
Net Income, 1 Yr. Growth %	95.76	-2.75	394.46	-64.92	-15.06
Normalized Net Income, 1 Yr. Growth %	93.2	-16.57	446.64	-58.65	-25.05
Diluted EPS Before Extra, 1 Yr. Growth %	93.33	-8.62	368.42	-65.17	-14.54
Accounts Receivable, 1 Yr. Growth %	16.22	19.11	36.14	19.58	26.48
Inventory, 1 Yr. Growth %	11.12	22.01	56.55	11.41	5.72
Net Property, Plant and Equip., 1 Yr. Growth %	19.83	58	55.3	31.4	26.51
Total Assets, 1 Yr. Growth %	23.04	61.51	97	-9.67	16
Tangible Book Value, 1 Yr. Growth %	34	94.24	54.8	7.45	8.6
Common Equity, 1 Yr. Growth %	32.51	98.71	58.39	5.91	7.7
Cash From Operations, 1 Yr. Growth %	312.87	-7.99	509.8	-104.62	-824.03
Capital Expenditures, 1 Yr. Growth %	47.86	96.77	51.71	17.22	-10.47
Levered Free Cash Flow, 1 Yr. Growth %	-80.51	1.06K	-800.72	-212.93	-78.46
Unlevered Free Cash Flow, 1 Yr. Growth %	-85.09	4.97K	-847.99	-211.78	-79.18
Dividend Per Share, 1 Yr. Growth %	-	-	57.51	-39.33	-23.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.09	15.87	99.62	32.02	-28.91
Gross Profit, 2 Yr. CAGR %	44.19	22.39	90.18	30.56	-20.51
EBITDA, 2 Yr. CAGR %	100.7	30.2	96.43	13.24	-33.26
EBITA, 2 Yr. CAGR %	113.72	28.2	108.2	3.67	-44.39
EBIT, 2 Yr. CAGR %	117.78	27.49	108.65	1.11	-45.89
Earnings From Cont. Operations, 2 Yr. CAGR %	133.83	38.62	121.63	17.03	-48.37
Net Income, 2 Yr. CAGR %	135.28	37.98	119.29	31.68	-45.42
Normalized Net Income, 2 Yr. CAGR %	125.27	33.54	113.56	50.34	-42.52
Diluted EPS Before Extra, 2 Yr. CAGR %	129.59	32.92	107.28	27.73	-45.44
Accounts Receivable, 2 Yr. CAGR %	17.5	17.66	27.34	27.59	22.98
Inventory, 2 Yr. CAGR %	21.06	16.44	38.21	32.06	8.52
Net Property, Plant and Equip., 2 Yr. CAGR %	20.81	37.63	56.65	42.85	28.93
Total Assets, 2 Yr. CAGR %	25.64	40.98	78.37	33.43	2.36
Tangible Book Value, 2 Yr. CAGR %	56.55	61.33	73.4	28.98	8.02
Common Equity, 2 Yr. CAGR %	51.88	62.27	77.41	29.53	6.81
Cash From Operations, 2 Yr. CAGR %	208.18	94.91	136.87	-46.91	-42.15
Capital Expenditures, 2 Yr. CAGR %	0.8	70.57	72.78	33.35	2.44
Levered Free Cash Flow, 2 Yr. CAGR %	-	-7.82	802.43	181.3	-51.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-6.88	1.85K	189.16	-52.32
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-2.25	-31.69
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	17.36	65.55	27.14	19.53
Gross Profit, 3 Yr. CAGR %	-	32.16	67.31	25.01	25.87
EBITDA, 3 Yr. CAGR %	-	59.2	92.71	6.13	22.84
EBITA, 3 Yr. CAGR %	-	60.96	106.13	-4.08	17.81
EBIT, 3 Yr. CAGR %	-	61.94	106.81	-6.44	16.74
Earnings From Cont. Operations, 3 Yr. CAGR %	-	75	112.75	10.32	10.12
Net Income, 3 Yr. CAGR %	-	75.26	111.15	19.03	13.77
Normalized Net Income, 3 Yr. CAGR %	-	67.32	113.62	23.54	21.78
Diluted EPS Before Extra, 3 Yr. CAGR %	-	68.88	102.52	14.38	11.72
Accounts Receivable, 3 Yr. CAGR %	-	18.03	23.52	24.7	27.22
Inventory, 3 Yr. CAGR %	-	21.38	28.52	28.63	22.62
Net Property, Plant and Equip., 3 Yr. CAGR %	-	32.14	43.29	47.73	37.18
Total Assets, 3 Yr. CAGR %	-	36.62	57.61	42.2	27.35
Tangible Book Value, 3 Yr. CAGR %	-	68.22	59.13	47.84	21.79
Common Equity, 3 Yr. CAGR %	-	66.12	60.97	49.39	21.8
Cash From Operations, 3 Yr. CAGR %	-	105.98	185.07	-36.23	26.85
Capital Expenditures, 3 Yr. CAGR %	-	25.98	64.04	51.82	16.77
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	81.17	351.38	18.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	86.4	650.68	19.35
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-9.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	23.02	18.05
Gross Profit, 5 Yr. CAGR %	-	-	-	31.28	24.24
EBITDA, 5 Yr. CAGR %	-	-	-	39.47	26.23
EBITA, 5 Yr. CAGR %	-	-	-	35.25	22.1
EBIT, 5 Yr. CAGR %	-	-	-	34.17	20.96
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	48.99	20.74
Net Income, 5 Yr. CAGR %	-	-	-	56.32	22.9
Normalized Net Income, 5 Yr. CAGR %	-	-	-	60.31	26.35
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	51.14	19.85
Accounts Receivable, 5 Yr. CAGR %	-	-	-	21.77	23.3
Inventory, 5 Yr. CAGR %	-	-	-	25.54	20.11
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	36.32	37.36
Total Assets, 5 Yr. CAGR %	-	-	-	35.33	32.63
Tangible Book Value, 5 Yr. CAGR %	-	-	-	51.26	36.29
Common Equity, 5 Yr. CAGR %	-	-	-	50.38	36.61
Cash From Operations, 5 Yr. CAGR %	-	-	-	19.76	50.63
Capital Expenditures, 5 Yr. CAGR %	-	-	-	28.88	35.88
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	7.15
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	8.04